Cargando…

Induction of Dendritic Cell–Mediated Activation of T Cells From Atherosclerotic Plaques by Human Heat Shock Protein 60

BACKGROUND: Atherosclerosis is characterized by the presence of activated immune‐competent cells including dendritic cells (DCs) and T cells, dead cells, and oxidized low‐density lipoprotein. HSP60 (Heat shock protein 60) has been implicated in atherosclerosis. A plasma protein, Annexin A5, has athe...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahman, Mizanur, Steuer, Johnny, Gillgren, Peter, Hayderi, Assim, Liu, Anquan, Frostegård, Johan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721770/
https://www.ncbi.nlm.nih.gov/pubmed/29151033
http://dx.doi.org/10.1161/JAHA.117.006778
_version_ 1783284877408337920
author Rahman, Mizanur
Steuer, Johnny
Gillgren, Peter
Hayderi, Assim
Liu, Anquan
Frostegård, Johan
author_facet Rahman, Mizanur
Steuer, Johnny
Gillgren, Peter
Hayderi, Assim
Liu, Anquan
Frostegård, Johan
author_sort Rahman, Mizanur
collection PubMed
description BACKGROUND: Atherosclerosis is characterized by the presence of activated immune‐competent cells including dendritic cells (DCs) and T cells, dead cells, and oxidized low‐density lipoprotein. HSP60 (Heat shock protein 60) has been implicated in atherosclerosis. A plasma protein, Annexin A5, has atheroprotective properties. METHODS AND RESULTS: Human DCs differentiated from peripheral blood monocytes were treated with human HSP60 or HSP90 and autologous T cells were cocultured with these pretreated DCs (mDCs). HSP60 induced mDCs and T‐cell activation as determined by FACScan (Fluorescence associated cell scan), gene‐activation, and cytokine production. HSP60‐induced T‐cell activation was partly major histocompatibility complex class II–dependent. T cells exposed to HSP60‐treated mDCs produced interferon‐γ, interleukin‐17, but not transforming growth factor‐β. HSP60 did not promote expression of Toll‐like receptors 2 or 4. HSP90 promoted mDCs maturation but had no effect on T‐cell activation. Annexin A5 inhibited HSP60‐proinflammatory Th1/Th17 effects on mDCs and T cells, and partly bound HSP60. Further, Annexin A5 inhibited HSP‐induced activation of mDCs and also oxidized low‐density lipoprotein–induced HSP‐production from mDCs. Experiments on mDCs and T cells derived from carotid atherosclerotic plaques from patients with symptomatic carotid disease gave similar results as from blood donors. CONCLUSIONS: HSP60 induces mDCs activation and partly major histocompatibility complex class II–dependent activation of blood‐ and plaque‐derived T cells, which is mostly of Th1/Th17 type. HSP60 could thus be an important T‐cell antigen in plaques, and also mediate oxidized low‐density lipoproteins immunogenic effects on DC‐T‐cell activation, promoting plaque rupture and clinical manifestations of cardiovascular disease. Annexin A5 inhibits both oxidized low‐density lipoprotein–induced HSP60, and HSP60‐mediated immune activation, which suggests a potential therapeutic role.
format Online
Article
Text
id pubmed-5721770
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-57217702017-12-12 Induction of Dendritic Cell–Mediated Activation of T Cells From Atherosclerotic Plaques by Human Heat Shock Protein 60 Rahman, Mizanur Steuer, Johnny Gillgren, Peter Hayderi, Assim Liu, Anquan Frostegård, Johan J Am Heart Assoc Original Research BACKGROUND: Atherosclerosis is characterized by the presence of activated immune‐competent cells including dendritic cells (DCs) and T cells, dead cells, and oxidized low‐density lipoprotein. HSP60 (Heat shock protein 60) has been implicated in atherosclerosis. A plasma protein, Annexin A5, has atheroprotective properties. METHODS AND RESULTS: Human DCs differentiated from peripheral blood monocytes were treated with human HSP60 or HSP90 and autologous T cells were cocultured with these pretreated DCs (mDCs). HSP60 induced mDCs and T‐cell activation as determined by FACScan (Fluorescence associated cell scan), gene‐activation, and cytokine production. HSP60‐induced T‐cell activation was partly major histocompatibility complex class II–dependent. T cells exposed to HSP60‐treated mDCs produced interferon‐γ, interleukin‐17, but not transforming growth factor‐β. HSP60 did not promote expression of Toll‐like receptors 2 or 4. HSP90 promoted mDCs maturation but had no effect on T‐cell activation. Annexin A5 inhibited HSP60‐proinflammatory Th1/Th17 effects on mDCs and T cells, and partly bound HSP60. Further, Annexin A5 inhibited HSP‐induced activation of mDCs and also oxidized low‐density lipoprotein–induced HSP‐production from mDCs. Experiments on mDCs and T cells derived from carotid atherosclerotic plaques from patients with symptomatic carotid disease gave similar results as from blood donors. CONCLUSIONS: HSP60 induces mDCs activation and partly major histocompatibility complex class II–dependent activation of blood‐ and plaque‐derived T cells, which is mostly of Th1/Th17 type. HSP60 could thus be an important T‐cell antigen in plaques, and also mediate oxidized low‐density lipoproteins immunogenic effects on DC‐T‐cell activation, promoting plaque rupture and clinical manifestations of cardiovascular disease. Annexin A5 inhibits both oxidized low‐density lipoprotein–induced HSP60, and HSP60‐mediated immune activation, which suggests a potential therapeutic role. John Wiley and Sons Inc. 2017-11-18 /pmc/articles/PMC5721770/ /pubmed/29151033 http://dx.doi.org/10.1161/JAHA.117.006778 Text en © 2017 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Research
Rahman, Mizanur
Steuer, Johnny
Gillgren, Peter
Hayderi, Assim
Liu, Anquan
Frostegård, Johan
Induction of Dendritic Cell–Mediated Activation of T Cells From Atherosclerotic Plaques by Human Heat Shock Protein 60
title Induction of Dendritic Cell–Mediated Activation of T Cells From Atherosclerotic Plaques by Human Heat Shock Protein 60
title_full Induction of Dendritic Cell–Mediated Activation of T Cells From Atherosclerotic Plaques by Human Heat Shock Protein 60
title_fullStr Induction of Dendritic Cell–Mediated Activation of T Cells From Atherosclerotic Plaques by Human Heat Shock Protein 60
title_full_unstemmed Induction of Dendritic Cell–Mediated Activation of T Cells From Atherosclerotic Plaques by Human Heat Shock Protein 60
title_short Induction of Dendritic Cell–Mediated Activation of T Cells From Atherosclerotic Plaques by Human Heat Shock Protein 60
title_sort induction of dendritic cell–mediated activation of t cells from atherosclerotic plaques by human heat shock protein 60
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721770/
https://www.ncbi.nlm.nih.gov/pubmed/29151033
http://dx.doi.org/10.1161/JAHA.117.006778
work_keys_str_mv AT rahmanmizanur inductionofdendriticcellmediatedactivationoftcellsfromatheroscleroticplaquesbyhumanheatshockprotein60
AT steuerjohnny inductionofdendriticcellmediatedactivationoftcellsfromatheroscleroticplaquesbyhumanheatshockprotein60
AT gillgrenpeter inductionofdendriticcellmediatedactivationoftcellsfromatheroscleroticplaquesbyhumanheatshockprotein60
AT hayderiassim inductionofdendriticcellmediatedactivationoftcellsfromatheroscleroticplaquesbyhumanheatshockprotein60
AT liuanquan inductionofdendriticcellmediatedactivationoftcellsfromatheroscleroticplaquesbyhumanheatshockprotein60
AT frostegardjohan inductionofdendriticcellmediatedactivationoftcellsfromatheroscleroticplaquesbyhumanheatshockprotein60